Industry·15 Aug 2024
INDUSTRY

A24 Raises at a $3.5 Billion Valuation

A24 has closed a funding round at a $3.5 billion valuation, roughly two and a half times its previous round. The number is the story. What the number implies is the longer story.

Written by Casey Winters, Industry Desk··5 min read·Industry
A stylised number 24 rendered in bold serif against a cream ground

A24 closed a $75 million funding round this week at a $3.5 billion post-money valuation, according to regulatory filings and multiple trade reports. The round was led by existing investor Stripes, with participation from unnamed new investors. The company has not publicly commented on the specific numbers.

The $3.5 billion valuation is roughly 2.5 times A24’s previous round in 2022, which valued the company at approximately $2.5 billion. It is an unusually aggressive markup for a specialty film studio in a theatrical market that, as I have written elsewhere, has been contracting for mid-budget releases across exactly the period A24 occupies.

What A24 actually is

A24, founded in 2012 by Daniel Katz, David Fenkel, and John Hodges, produces and distributes films across a specific niche: director-driven, mid-to-low-budget, adult-audience theatrical releases. The company’s filmography includes Room (2015), Moonlight (2016), Lady Bird (2017), Hereditary (2018), Midsommar (2019), Uncut Gems (2019), Everything Everywhere All at Once (2022), and most recently The Zone of Interest (2023), The Iron Claw (2023), Civil War (2024), and MaXXXine (2024).

The company’s production and acquisition model is structurally different from the major studios. A24 rarely develops films in-house across a full production cycle; instead, it co-finances or acquires completed or near-completed films at specific stages and provides theatrical distribution, marketing, and awards-campaign support. This model allows A24 to operate at a significantly smaller overhead than comparable studios.

What the valuation implies

At a $3.5 billion valuation on approximately $280 million in annual revenue (the estimate commonly cited in trade publications, though A24 does not publicly disclose), the company is trading at roughly 12.5 times revenue. This is, for a specialty film distributor, an aggressive multiple.

For comparison: Lionsgate, a publicly-traded specialty studio with a similar content profile, trades at approximately 0.8 times revenue. Legendary Entertainment, another specialty studio, was valued at approximately 2 times revenue in its most recent disclosed round. The A24 valuation is specifically priced for growth, not for the current operating business.

What is the growth thesis? Based on public statements from A24 leadership and the structure of recent investments, the thesis appears to include:

  • Television expansion. A24 has been increasing its television production volume across the last three years, with Euphoria, Beef, Mr. and Mrs. Smith, and The Curse as anchor productions. Television generates substantially higher recurring revenue than theatrical for a studio of A24’s size.
  • Brand extension. A24 has licensed its brand into merchandise, publishing, and event properties. The brand itself has accumulated a specific commercial value that the valuation is partly capturing.
  • Selective franchise development. The company has hinted at developing sequels or spinoffs for a small number of its successful properties. This is a departure from the traditionally one-film-per-property approach.

Why the valuation is being priced this way

Two complementary explanations.

First, the scarcity premium. There are very few remaining independent-studio assets at A24’s quality and scale. Most specialty studios have been acquired by larger media companies (Searchlight by Disney, Focus by Universal, Neon remains independent but smaller). A24 is, effectively, the last major independent specialty studio with an identifiable brand. Investors willing to take exposure to specialty film have limited alternative investments at this scale.

Second, the growth optionality. The valuation is priced for a specific acquisition scenario. At some point in the next three to five years, A24 is likely to either go public via IPO or be acquired by a larger media entity. Both outcomes would, based on public-market comparables and recent private-market acquisition multiples, plausibly justify a valuation at or above the current round price.

The acquisition candidates

The trade press has, for the last eighteen months, been speculating about potential A24 acquirers. The names most commonly floated include: Amazon (which has demonstrated willingness to pay premium prices for specialty content through the MGM deal); Apple (which has been developing its prestige-content slate and would benefit from A24’s taste-maker positioning); Netflix (less likely given Netflix’s scale and cultural distance from A24’s audience); and a potential private-equity consortium structured around eventual IPO.

None of these have been confirmed. A24’s founders have, on multiple occasions, indicated a preference for remaining independent. The current round’s structure (primarily existing-investor follow-on) suggests that immediate exit pressure is low.

What A24 needs to prove

The $3.5 billion valuation is priced for specific commercial delivery over the next three years.

A24’s film slate for the current commercial year includes Heretic (2024), We Live in Time (2024), Queer (2024), Babygirl (2024), and The Brutalist (via secondary distribution in selected markets). The slate is, by the studio’s standards, strong. Whether it generates the box-office performance required to validate the growth thesis is the near-term commercial question.

The television slate is the longer-term question. Euphoria’s third season has been delayed into 2025 for scheduling reasons. The other prestige-television productions (Beef, The Curse, Mr. and Mrs. Smith) have received strong critical reception but have not, so far, translated to dominant cultural-penetration numbers.

A24 is, as of this writing, one of the most strategically interesting companies in American media. Its commercial model is real. Its brand is unique. Its valuation is priced for an acquisition scenario that has not yet materialised. The next two years will determine whether the valuation was prescient or whether it was the top of a specialty-studio investment cycle.

I am, cautiously, betting on prescient. The alternative specialty-studio ecosystem is weaker than it has been in a decade. A24 benefits from the weakness.

WRITTEN BY
Casey Winters
INDUSTRY DESK

Casey covers the business of film and television for Frame Junkie. Previously five years on the trade-publication beat; refuses to share the exact masthead. Writes short, rarely takes a side, usually gets the number right.

MORE BY CASEY WINTERS
KEEP READING